Snapshot · The Mel Robbins Podcast
Stanford professor Tina Seelig's research shows that lucky people intentionally put themselves in the current of what they want by taking small actions to collide with opportunity.
Where this was said
At 37:01 · chapter starts 36:00
Oakley's January reset was comprehensive: he rejoined the Frisbee team, went to every party, texted acquaintances he had previously been too proud to pursue, got lunch with strangers, and kept repeating the pattern even when early interactions were awkward. Mel connects this to Stanford professor Tina Seelig's research [1] — Mel Robbins "Stanford science of luck research: Stanford professor Tina Seelig's research shows that lucky people intentionally put themselves in the cu…" 37:01 : lucky people are not just fortunate — they engineer their luck by intentionally placing themselves in situations where desired collisions can happen. The more people you say hello to, the more lunches you schedule, the more rooms you walk into with an open attitude, the greater your statistical chance of finding the people and opportunities you are looking for. Oakley's accumulation of small yeses — each individually awkward — eventually produced close friendships and a genuine love of college.
Stanford professor Tina Seelig's research demolishes the idea that luck is random. Lucky people intentionally put themselves in the current of what they want — they say yes, they show up, they reach out first. Oakley proved this by texting the mutuals he'd been too proud to contact, and it changed everything.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.